MHRA Drug Safety Update June 2017
Posted on:
MHRA Drug Safety Update June 2017
A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (vol 10, issue 11, June 2017) has been published and includes articles on:
- Denosumab (Prolia, Xgeva▼): reports of osteonecrosis of the external auditory canal
- Brimonidine gel (Mirvaso): risk of systemic cardiovascular effects; not to be applied to damaged skin
- Pseudoephedrine and ephedrine: regular review of minimising risk of misuse in the UK
- e-cigarettes and refill containers (e-liquids): report suspected side effects and safety concerns
- Letters sent to healthcare professionals in May 2017
- Medical Device Alerts issued in May 2017